Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Short-term Investments (2016 - 2018)

Lifecore Biomedical, Inc. \De\ (LFCR) has 6 years of Short-term Investments data on record, last reported at $1.5 million in Q2 2018.

  • For Q2 2018, Short-term Investments rose 122.24% year-over-year to $1.5 million; the TTM value through May 2018 reached $1.5 million, up 122.24%, while the annual FY2018 figure was $1.5 million, 122.24% up from the prior year.
  • Short-term Investments reached $1.5 million in Q2 2018 per LFCR's latest filing, up from $909000.0 in the prior quarter.
  • Across five years, Short-term Investments topped out at $1.5 million in Q2 2018 and bottomed at $519000.0 in Q4 2016.
  • Average Short-term Investments over 3 years is $809000.0, with a median of $684500.0 recorded in 2017.
  • Peak YoY movement for Short-term Investments: skyrocketed 75.14% in 2017, then soared 122.24% in 2018.
  • A 3-year view of Short-term Investments shows it stood at $519000.0 in 2016, then surged by 75.14% to $909000.0 in 2017, then surged by 68.21% to $1.5 million in 2018.
  • Per Business Quant database, its latest 3 readings for Short-term Investments were $1.5 million in Q2 2018, $909000.0 in Q4 2017, and $528000.0 in Q3 2017.